Figure 1.
Treatment continuity (n=40).
Note: 40 patients received a median number of 7.5 cycles of XELOX + BV; range= 2–40 cycles.
Abbreviations: BV, bevacizumab; CR, complete response; PD, progression disease; AEs, adverse events.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.